Semaglutide
Typical Dosage
0.25-2 mg
Administration
Injection
Half-Life
Approximately 7 days
Mechanism of Action
Weight-loss and diabetes research|Appetite regulation|Cardiometabolic outcomes|GLP-1 pharmacology
Research Protocol Summary
Evidence Level
Human Clinical / Marketed
Typical Protocol Duration
8-48 weeks
Species Studied
Human • Mouse • Rat
Administration Schedule
Once Weekly
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…